BioCentury’s roundup of translational innovations also includes targeting MSH3 to slow repeat expansion in Huntington’s; plus AAVs for kidney and T cells

Plus: Shawnte Mitchell joins Olema as chief legal and updates from Loqus23, Pheast, Crafton, Eupraxia and more

BioCentury’s roundup of translational innovations also includes new insight into repeat expansion in Huntington’s and 10 new products

But partnership lands fourth on overall upfront payment

Biotech retains upside in licensing agreement for oral therapy derived from same splicing platform as SMA drug

CEO Ingram sees “the one significant strategic transaction” to transform Sarepta’s future, while Arrowhead preps for first-ever launch

BioCentury’s roundup of translational innovations also includes a study from Amgen and a newco spotlight

Deals report: Pfizer-Triana to discover molecular glues; Novartis taps Baiyu for cancer small molecule; plus Ocean-Molecure, Takeda-Wave and more

In first human RNA-editing data, Wave reports positive results from WVE-006 in alpha-1 antitrypsin deficiency

The tools exist, it’s time to embrace them. Long-read sequencing is just one of the force-multipliers at hand